A Basic Course on the Clinical Applications of Botulinum Neurotoxin
Cynthia Comella (USA)
Mark Hallett (USA)
Giampietro Schiavo (UK)
Anthony Ward (UK)
This is a four-hour educational event designed as an overview of the use of botulinum neurotoxin in clinical practice. The target audience is clinicians (including those in training) who have relatively limited experience with botulinum neurotoxin, as well as interested basic scientists. This is an introductory program to provide basic knowledge of the clinical uses of botulinum neurotoxin. This course will provide a foundation of knowledge for more in-depth sessions to be held during the TOXINS 2019 main program. It is designed to allow those attending an insight into the principles of patient assessment, decision-making, and treatment approaches in managing people with a range of disabling conditions using botulinum neurotoxin. The course will focus on common disorders that are treated with botulinum neurotoxin.
The program will include didactic presentations, case histories, and videos. It will focus on practical issues, such as diagnosis, muscle selection and injection, determination of botulinum neurotoxin dosages, and recognition and management of adverse effects. It will provide ample opportunity for participant interaction.
Wednesday, 16 January, 2019
| 12:00 – 12:10 | Welcome and Introduction: The Diverse Clinical Uses of Botulinum Neurotoxins Cynthia Comella (USA) & Anthony Ward (UK) |
| 12:10 – 12:40 | Botulinum Neurotoxins: Serotypes and Mechanism of Action Giampietro Schiavo (UK) |
| 12:40 – 13:25 | Botulinum Neurotoxin for the Treatment of Spasticity in Adults and Children Anthony Ward (UK) |
| 13:25 – 13:55 | Botulinum Neurotoxin for the Treatment of Cervical Dystonia Cynthia Comella (USA) |
| 13:55 – 14:15 | Break |
| 14:15 – 14:45 | Botulinum Neurotoxin for the Treatment of Other Movement Disorders: Limb Dystonia and Blepharospasm Mark Hallett (USA) |
| 14:45 – 15:00 | Self-Assessment: Clinical Quiz Anthony Ward (UK) |
| 15:00 – 16:00 | Case Histories and Patient Studies Cynthia Comella (USA) & Anthony Ward (UK) Delegates to divide into groups for developing treatment programs |
